BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19472035)

  • 1. Polymyositis and myocarditis after donor lymphocyte infusion.
    Ahn JS; Cho SH; Kim YK; Yang DH; Bae WK; Shim HJ; Lee JJ; Chung IJ; Juhng SW; Kim HJ
    Int J Hematol; 2009 Jul; 90(1):113-116. PubMed ID: 19472035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyositis after donor lymphocyte infusion.
    Montoro J; Hernández-Boluda JC; Arbona C; Solano C
    Int J Hematol; 2012 Sep; 96(3):386-9. PubMed ID: 22903864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute polymyositis after donor lymphocyte infusion.
    Lin PC; Hsiao LT; Chen PM
    Eur J Haematol; 2005 Feb; 74(2):166-8. PubMed ID: 15654909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic GVHD complicated with polymyositis and cardiomyopathy after myeloablative hematopoietic stem cell transplantation].
    Morimoto Y; Oka S; Tashima M; Hamahata K; Nohgawa M
    Rinsho Ketsueki; 2015 May; 56(5):485-90. PubMed ID: 26062670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic graft-versus-host disease-related polymyositis and myocarditis: A case report and review of the literature.
    Yan M; Su F; Cheng F; Shi J; Zheng W; Luo Y; Wang J; Lu H; Zhou H; Huang H; Tan Y
    Transpl Immunol; 2022 Jun; 72():101598. PubMed ID: 35381344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyositis complicating donor lymphocyte infusion after stem cell transplantation for relapsed chronic myeloid leukemia: report of a case and review of literature.
    Liu FC; Chen CH; Chao TY
    Clin Rheumatol; 2007 Jul; 26(7):1207-10. PubMed ID: 16937070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
    Couriel DR; Beguelin GZ; Giralt S; De Lima M; Hosing C; Kharfan-Dabaja MA; Anagnostopoulos A; Champlin R
    Bone Marrow Transplant; 2002 Oct; 30(8):543-6. PubMed ID: 12379897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapsing polymyositis in chronic graft versus host disease.
    Sharaf N; Prayson RA
    J Clin Neurosci; 2014 Nov; 21(11):1964-5. PubMed ID: 24980629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
    Radujkovic A; Guglielmi C; Bergantini S; Iacobelli S; van Biezen A; Milojkovic D; Gratwohl A; Schattenberg AV; Verdonck LF; Niederwieser DW; de Witte T; Kröger N; Olavarria E;
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1230-6. PubMed ID: 25797175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyositis--an unusual manifestation of chronic graft-versus-host disease.
    George B; Danda D; Chandy M; Srivastava A; Mathews V
    Rheumatol Int; 2001 May; 20(4):169-70. PubMed ID: 11411964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of chronic graft-versus-host disease presenting with polymyositis].
    Okazaki T; Maeda A; Inoue M; Kitazono T; Shibata T; Ozaki S
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):124-8. PubMed ID: 19404011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyositis as a manifestation of chronic graft-versus-host disease.
    Parker P; Chao NJ; Ben-Ezra J; Slatkin N; Openshaw H; Niland JC; Linker CA; Greffe BS; Kashyap A; Molina A; Nademanee A; O'Donnell MR; Planas I; Sheibani K; Smith EP; Snyder DS; Spielberger R; Stein AS; Stepan DE; Blume KG; Forman SJ
    Medicine (Baltimore); 1996 Sep; 75(5):279-85. PubMed ID: 8862349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease-Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed Acute Leukemia.
    Yan CH; Liu QF; Wu DP; Zhang X; Xu LP; Zhang XH; Wang Y; Huang H; Bai H; Huang F; Ma X; Huang XJ
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1311-1319. PubMed ID: 28483716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
    Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the safety and efficacy of prophylactic donor lymphocyte infusion after haploidentical versus matched-sibling PBSCT in very high-risk acute myeloid leukemia.
    Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
    Ann Hematol; 2019 May; 98(5):1267-1277. PubMed ID: 30747249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and Severity of Donor Lymphocyte Infusion-Associated Chronic Graft-versus-Host Disease Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.
    Yu WJ; Mo XD; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Biol Blood Marrow Transplant; 2019 May; 25(5):912-920. PubMed ID: 30485788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An autopsy case of polymyositis with exacerbation of chronic myocarditis].
    Arimura Y; Ohi T; Shiomi K; Yamashita A; Asada Y
    No To Shinkei; 2003 Jul; 55(7):599-604. PubMed ID: 12910994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant.
    Alyea EP; Soiffer RJ; Canning C; Neuberg D; Schlossman R; Pickett C; Collins H; Wang Y; Anderson KC; Ritz J
    Blood; 1998 May; 91(10):3671-80. PubMed ID: 9573003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors.
    Yan CH; Wang JZ; Liu DH; Xu LP; Chen H; Liu KY; Huang XJ
    Eur J Haematol; 2013 Oct; 91(4):304-14. PubMed ID: 23837640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyositis as a manifestation of chronic graft-versus-host disease.
    Stevens AM; Sullivan KM; Nelson JL
    Rheumatology (Oxford); 2003 Jan; 42(1):34-9. PubMed ID: 12509610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.